AnnJi Pharmaceutical Advances AJ201 to Phase III ROMA-KD Study for SBMA Treatment #Taipei #USA #AnnJi_Pharmaceutical #AJ201 #SBMA

AnnJi Pharmaceutical Advances AJ201 to Phase III ROMA-KD Study for SBMA Treatment #Taipei #USA #AnnJi_Pharmaceutical #AJ201 #SBMA
AnnJi Pharmaceutical's AJ201 Advances to Pivotal Phase 3 Trial for Rare Muscle Atrophy Disease #Taipei #USA #AnnJi_Pharmaceutical #AJ201 #SBMA
AnnJi Pharmaceutical's Pioneering Phase 3 Trial for SBMA with AJ201 Marks a Milestone in Treatment Options #Taipei #USA #AnnJi_Pharmaceutical #AJ201 #SBMA